VIVS:NASDAQ, VivoSim Labs, Inc.

Why VIVS stock rose on November 11

VivoSim Labs, Inc. rose 15.4% on Wednesday, November 11, 2026, on 6,966,800 shares, 7.0 times its average daily volume. The headline around the move:

VIVS stock overview

VivoSim Labs, Inc. (VIVS:NASDAQ) closed at $0.124 on November 16, 2026, down 2.68% on the day. The stock trades 96.4% below its 52-week high of $3.40 and 3.1% above its 52-week low of $0.120. Over the past year, it lost 94.5%. VivoSim Labs, Inc. is part of the Health Care sector.

Key figures

Price
$0.124
Day change
-2.68%
Volume
229,750
Average volume
995,521
Market cap
2M+
52-week range
$0.120 – $3.40
50-day average
$0.194
200-day average
$0.985

Price action over the past year

In 252 trading sessions since November 14, 2025, VIVS closed higher on 76 days (30%). Its best day was January 30, 2026 (+71.76%) and its worst was July 16, 2026 (-28.24%). The stock moved 10% or more in a single session 25 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

VIVS news

About VivoSim Labs, Inc.

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.

Similar stocks

Find more stocks like VIVS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.